View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsQuanta 배당 및 자사주 매입배당 기준 점검 0/6핵심 정보n/a배당 수익률-1,920.4%자사주 매입 수익률총 주주 수익률-1,920.4%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Aug 17Quanta, Inc. announced delayed 10-Q filingOn 08/16/2022, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • May 17Quanta, Inc. announced delayed 10-Q filingOn 05/16/2022, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Mar 29Quanta, Inc. announced delayed annual 10-K filingOn 03/28/2022, Quanta, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Aug 14Quanta, Inc. announced delayed 10-Q filingOn 08/13/2021, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • May 12Quanta, Inc. announced delayed 10-Q filingOn 05/11/2021, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Apr 02Quanta, Inc. announced delayed annual 10-K filingOn 03/31/2021, Quanta, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Dec 23Quanta, Inc. (OTCPK:QNTA) entered into an agreement to acquire 51% stake in Medolife International, Inc.Quanta, Inc. (OTCPK:QNTA) entered into an agreement to acquire 51% stake in Medolife International, Inc. on December 21, 2020. In exchange, Quanta will issue 9000 shares newly created Series B Convertible Preferred Stock. Arthur G. Mikaelian, Ph.D was appointed as a member of the Board of Directors of Quanta, Inc and was also appointed to serve as the Company’s Chief Executive Officer. The acquisition is subject to customary due diligence by both parties, and to the approval of Quanta, Inc. shareholders.공시 • Nov 19Quanta, Inc. Announces Change of CEOThe Directors of Quanta, Inc. announced that pursuant to the Company's Transition to a Holding Company, Phil Sands was previously appointed as a member of the Company's Board of Directors. Mr. Sands also appointed as the Company's Chief Executive Officer, with such appointment as CEO to be effective ten days following the mailing of a Schedule 14F Information Statement to the Company's Shareholders. The appointment of Mr. Sands as CEO, the Company has received and hereby accepts the resignation letter of Eric Rice from all officer positions with the Company, to be effective ten days following the mailing of the Schedule 14F Information Statement to the Company's Shareholders.공시 • Nov 14Quanta, Inc. Appoints Phil Sands as Member of the Board of DirectorsOn November 13, 2020, Mr. Phil Sands was appointed as a member of the Board of Directors of Quanta, Inc. Mr. Phil Sands, age 59, brings over 20 plus years of corporate executive experience, business development, project management, investment consultation, and B2B sales experience within Small Business and Corporate America. He has served in diverse companies with positions of Investment Consultant, Business Development Manager, Director of Investor Relations and Principal of small businesses. Mr. Sands has through collaboration worked with investment firms and helped developed strategies for public and private funding offerings, debt debenture offerings, help with Private Placements, balance sheet review and offer investment location consultation, client presentation, coaching, and access to market makers and broker dealers. Has worked with clients from all sectors with diverse back grounds on the OTC markets as well NASDAQ companies. Sectors range from alternative energy, technical, medical, manufacturing and more.공시 • Nov 13Quanta, Inc. announced delayed 10-Q filingOn 11/12/2020, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Aug 15Quanta, Inc. announced delayed 10-Q filingOn 08/14/2020, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 QNTA 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: QNTA 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Quanta 배당 수익률 vs 시장QNTA의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (QNTA)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.2%업계 평균 (Pharmaceuticals)2.1%분석가 예측 (QNTA) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 QNTA 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 QNTA 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 QNTA 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: QNTA 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2023/05/17 19:48종가2023/05/15 00:00수익2022/03/31연간 수익2021/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Quanta, Inc.는 0명의 분석가가 다루고 있습니다. 이 중 명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Aug 17Quanta, Inc. announced delayed 10-Q filingOn 08/16/2022, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • May 17Quanta, Inc. announced delayed 10-Q filingOn 05/16/2022, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Mar 29Quanta, Inc. announced delayed annual 10-K filingOn 03/28/2022, Quanta, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Aug 14Quanta, Inc. announced delayed 10-Q filingOn 08/13/2021, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • May 12Quanta, Inc. announced delayed 10-Q filingOn 05/11/2021, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Apr 02Quanta, Inc. announced delayed annual 10-K filingOn 03/31/2021, Quanta, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Dec 23Quanta, Inc. (OTCPK:QNTA) entered into an agreement to acquire 51% stake in Medolife International, Inc.Quanta, Inc. (OTCPK:QNTA) entered into an agreement to acquire 51% stake in Medolife International, Inc. on December 21, 2020. In exchange, Quanta will issue 9000 shares newly created Series B Convertible Preferred Stock. Arthur G. Mikaelian, Ph.D was appointed as a member of the Board of Directors of Quanta, Inc and was also appointed to serve as the Company’s Chief Executive Officer. The acquisition is subject to customary due diligence by both parties, and to the approval of Quanta, Inc. shareholders.
공시 • Nov 19Quanta, Inc. Announces Change of CEOThe Directors of Quanta, Inc. announced that pursuant to the Company's Transition to a Holding Company, Phil Sands was previously appointed as a member of the Company's Board of Directors. Mr. Sands also appointed as the Company's Chief Executive Officer, with such appointment as CEO to be effective ten days following the mailing of a Schedule 14F Information Statement to the Company's Shareholders. The appointment of Mr. Sands as CEO, the Company has received and hereby accepts the resignation letter of Eric Rice from all officer positions with the Company, to be effective ten days following the mailing of the Schedule 14F Information Statement to the Company's Shareholders.
공시 • Nov 14Quanta, Inc. Appoints Phil Sands as Member of the Board of DirectorsOn November 13, 2020, Mr. Phil Sands was appointed as a member of the Board of Directors of Quanta, Inc. Mr. Phil Sands, age 59, brings over 20 plus years of corporate executive experience, business development, project management, investment consultation, and B2B sales experience within Small Business and Corporate America. He has served in diverse companies with positions of Investment Consultant, Business Development Manager, Director of Investor Relations and Principal of small businesses. Mr. Sands has through collaboration worked with investment firms and helped developed strategies for public and private funding offerings, debt debenture offerings, help with Private Placements, balance sheet review and offer investment location consultation, client presentation, coaching, and access to market makers and broker dealers. Has worked with clients from all sectors with diverse back grounds on the OTC markets as well NASDAQ companies. Sectors range from alternative energy, technical, medical, manufacturing and more.
공시 • Nov 13Quanta, Inc. announced delayed 10-Q filingOn 11/12/2020, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Aug 15Quanta, Inc. announced delayed 10-Q filingOn 08/14/2020, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.